Beagle Bioproducts
About Beagle Bioproducts
Beagle Bioproducts, Inc. was founded in January 2012 with the intent to emerge as the most reliable domestic supplier of cyanobacterial toxins for research and for the monitoring and mitigation of harmful algal blooms (HABs). Our products will be available consistently and affordably, and we will develop a new line of lower-grade toxin products for research applications that don’t require high-purity (and high-cost) toxins. Upon establishing ourselves in the U.S. market, we intend to expand to global markets so that these products will be available to people studying and mitigating HABs worldwide.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 21 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 440000 USD
- Last Funding: 60000 USD (Seed)
- Funding Status: Seed
Technology Stack
Beagle Bioproducts actively uses 21 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Retail
Headquarters: Columbus, Ohio, United States